01 5Duodopa
02 10Madopar
03 1Sinemet
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 494
2019 Revenue in Millions : 461
Growth (%) : 7
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 511
2020 Revenue in Millions : 494
Growth (%) : 3
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 458
2021 Revenue in Millions : 511
Growth (%) : -10
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 468
2022 Revenue in Millions : 458
Growth (%) : 2
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 461
2018 Revenue in Millions : 430
Growth (%) : 7
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 378
2018 Revenue in Millions : 351
Growth (%) : 8
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 402
2019 Revenue in Millions : 409
Growth (%) : -2
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 424
2020 Revenue in Millions : 383
Growth (%) : 9
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 71
2020 Revenue in Millions : 77
Growth (%) : -8
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 414
2021 Revenue in Millions : 424
Growth (%) : -2
LOOKING FOR A SUPPLIER?